Status:
UNKNOWN
Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer
Lead Sponsor:
San Diego Radiosurgery
Conditions:
Prostate Cancer
Eligibility:
MALE
18-99 years
Phase:
PHASE1
Brief Summary
The purpose of this trial is to evaluate a short course of very focused (stereotactic) external beam radiation therapy for the treatment of early stage prostate cancer. The investigators will gather ...
Eligibility Criteria
Inclusion
- Histologically confirmed adenocarcinoma of the prostate
- Gleason score ≤ 6 and low volume Gleason 7 (3+4)
- PSA \< 10
- Clinical Stage of T2a or less
- Ability to understand and the willingness to sign a written informed consent document
Exclusion
- Prior radiation treatment for prostate cancer
- Gleason score \> 7
- PSA \> 10
- Clinical Stage of T2b or greater
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00969202
Start Date
August 1 2009
End Date
December 1 2016
Last Update
November 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Diego Radiosurgery at Palomar Medical Center
Escondido, California, United States, 92025